Europe Coronary and Peripheral Stents Market Outlook (2022-2033)

The Europe coronary and peripheral stents market size is expected to reach US$ 5,061.2 million by 2033 from US$ 2,567.3 million in 2024. The market is estimated to record a CAGR of 8.0% from 2025 to 2033.

Executive Summary and Europe Coronary and Peripheral Stents Market Analysis:

Europe’s coronary and peripheral stents market is a mature and second‑dominating region globally, characterized by established clinical practices, strong regulatory frameworks, and widespread adoption of advanced stent technologies. The region benefits from a well‑developed healthcare infrastructure, high physician expertise, and consistent integration of drug‑eluting and bioresorbable stents into routine cardiovascular care. Germany leads the market, supported by its robust hospital network, strong reimbursement systems, and active participation in clinical research. Key drivers include aging demographics and high prevalence of cardiovascular disease, which sustain demand for coronary and peripheral interventions. However, restraints such as stringent regulatory approval processes and cost‑containment measures across public health systems can slow the introduction of innovative devices. Despite these challenges, Europe remains a critical hub for technological advancement and clinical adoption, reinforcing its role as the second most influential region in shaping global stent market dynamics.

Europe Coronary and Peripheral Stents Market Segmentation Analysis

Key segments that contributed to the derivation of the coronary and peripheral stents market analysis are product type, material type, application and end user.

• By product type, the coronary and peripheral stents market is segmented into bare-metal stents, drug-eluting stents, bioresorbable vascular scaffolds, and others. The drug-eluting stents segment dominated the market in 2024. Superior efficacy in reducing restenosis, longer-term patient outcomes, and widespread physician preference drove adoption, making them the most trusted choice compared to bare-metal or bioresorbable alternatives.
• By material type, the coronary and peripheral stents market is segmented into metal, polymer, and hybrid. The metal segment dominated the market in 2024. High durability, proven biocompatibility, cost-effectiveness, and established clinical success ensured dominance, as polymer and hybrid options remain limited in availability, scalability, and long-term performance validation.
• By application, the coronary and peripheral stents market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment dominated the market in 2024. Higher global prevalence, significant clinical burden, and greater demand for interventional procedures positioned coronary stents as the leading application, overshadowing peripheral artery disease interventions in overall market share.
• By end user, the market is segmented into hospitals, ambulatory surgical centers, cardiac catheterization labs, and specialty clinics. The hospitals segment held the largest share of the market in 2024. Comprehensive infrastructure, advanced catheterization facilities, skilled specialists, and ability to handle complex cases ensured hospitals remained the primary setting for stent implantation, surpassing smaller clinics and ambulatory centers.  

Europe Coronary and Peripheral Stents Market Outlook

The European market is defined by its maturity, with coronary drug‑eluting stents and nitinol peripheral stents firmly entrenched in clinical practice. Hospitals and specialized cardiovascular centers dominate procurement, supported by structured reimbursement pathways and harmonized treatment guidelines. A major driver is the aging population, which significantly increases the incidence of coronary artery disease and peripheral artery disease across the region. As life expectancy rises, the demand for minimally invasive interventions grows, prompting hospitals to expand catheterization capacity and adopt advanced stent technologies. This demographic trend not only sustains procedural volumes but also encourages innovation in stent design, focusing on durability, biocompatibility, and long‑term outcomes. The aging population thus acts as a structural driver, ensuring steady demand for coronary and peripheral stents, while Europe’s mature healthcare systems provide the framework for consistent adoption and integration of new technologies.

Europe Coronary and Peripheral Stents Market Country Insights

Based on country, the Europe coronary and peripheral stents market is further segmented into Germany, Italy, France, U.K., Spain, Belgium, the Netherlands, Luxembourg, Norway, Finland, Denmark, Sweden, Austria, Switzerland, Russia, Romania, Greece, the Czech Republic, Portugal, Ukraine, Poland, Slovakia and Bulgaria. Germany held the largest share in 2024.

Germany dominates the European coronary and peripheral stents market, leveraging its advanced healthcare infrastructure, strong reimbursement policies, and leadership in clinical research. The country’s extensive hospital network and specialized cardiovascular centers ensure high procedural volumes, with drug‑eluting stents widely adopted as the standard of care. Germany’s role as a hub for medical device innovation is reinforced by collaborations between domestic manufacturers, global leaders such as Abbott, Boston Scientific, and Medtronic, and academic institutions engaged in clinical trials. Peripheral stent adoption is also expanding, driven by rising awareness of peripheral artery disease and the availability of advanced nitinol solutions. Regulatory efficiency and structured procurement systems allow timely access to new technologies, while physician training programs maintain high standards of care. Germany’s dominance stems from its ability to combine innovation, affordability, and clinical expertise, positioning it as the benchmark for coronary and peripheral stent utilization across Europe.

Europe Coronary and Peripheral Stents Market Company Profiles

Medtronic, Boston Scientific Corporation, Abbott, B. Braun SE, TERUMO CORPORATION, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Cook Medical, Meril Life Sciences and Translumina are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

Europe Coronary and Peripheral Stents Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

• Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Europe Coronary and Peripheral Stents Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• European Society of Cardiology
• American College of Cardiology
• American Heart Association
• Asian Pacific Society of Interventional Cardiology
• Company website
• Company annual reports
• Company investor presentations